Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Buy

Price to Earnings Rating

Buy

Analyst Rating

Neutral

Aligos Therapeutics, Inc. Common Stock (ALGS)

Biological Products, (no Disgnostic Substances)

https://www.aligos.com

Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

ONE CORPORATE DR., 2ND FLOOR
SOUTH SAN FRANCISCO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/16/2020

Market Cap

39,787,684

Shares Outstanding

71,840,000

Weighted SO

74,931,848

Total Employees

N/A

Upcoming Earnings

08/01/2024

Beta

2.1830

Last Div

0.0000

Range

0.348-1.2

Chg

0.0379

Avg Vol

461325

Mkt Cap

39787684

Exch

NASDAQ

Country

US

Phone

800 466 6059

DCF Diff

0.3604

DCF

0.1426

Div Yield

0.0000

P/S

4.9941

EV Multiple

-0.0489

P/FV

1.2054

Div Yield %

0.0000

P/E

-1.0700

PEG

-0.0383

Payout

0.0000

Current Ratio

4.2255

Quick Ratio

4.2255

Cash Ratio

1.9160

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

908.3704

CCC

-908.3704

Gross Margin

0.6561

Op Margin

-11.7394

Pretax Margin

-9.4795

Net Margin

-9.5061

Eff Tax Rate

-0.0022

ROA

-0.6960

ROE

-1.1059

ROCE

-1.0971

NI/EBT

1.0028

EBT/EBIT

0.8075

EBIT/Rev

-11.7394

Debt Ratio

0.0904

D/E

0.1463

LT Debt/Cap

0.0879

Total Debt/Cap

0.1276

Int Coverage

6.7798

CF/Debt

-8.6645

Equity Multi

1.6185

Rec Turnover

0.0000

Pay Turnover

0.4018

Inv Turnover

0.0000

FA Turnover

0.9253

Asset Turnover

0.0732

OCF/Share

-0.5448

FCF/Share

-0.5454

Cash/Share

0.6047

OCF/Sales

-10.6983

FCF/OCF

1.0011

CF Coverage

-8.6645

ST Coverage

-25.4048

CapEx Coverage

-897.1895

Div&CapEx Cov

-897.1895

P/BV

1.2054

P/B

1.2054

P/S

4.9941

P/E

-1.0700

P/FCF

-0.4663

P/OCF

-0.9508

P/CF

-0.9508

PEG

-0.0383

P/S

4.9941

EV Multiple

-0.0489

P/FV

1.2054

DPS

0.0000

Latest Headlines (EST)

Revenue Product Segmentation